This was a result of timing of vaccine authorization (children became eligible for second doses in late November 2021 and adolescents in late May 2021) and by the end of the study period (test dates were only included through February 21, 2022). Table. Characteristics of Included Tests in ...
T. et al. Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19. ACS Cent. Sci. 6, 672–683 (2020). Article CAS PubMed PubMed Central Google Scholar Wittwer, K. et al. Small-molecule polymerase inhibitor protects non-...